[摘要] 目的 探讨大剂量地塞米松治疗成人原发性免疫性血小板减少症合并糖尿病的效果。方法 选取2016年5月—2018年5月该科收治的ITP合并糖尿病患者22例，随机分为两组各11例，观察组采用大剂量地塞米松，对照组采用泼尼松。结果 观察组总有效率为81.8%，显著优于对照组63.6%(P<0.05);观察组FPG显著低于对照组，PLT明显高于对照组(P<0.05)。结论 ITP合并糖尿病患者采用大剂量地塞米松治疗效果显著，对血糖无明显影响，安全性高，值得应用。

    [关键词] 地塞米松;原发性免疫性血小板减少症;糖尿病

    [中图分类号] R587.1 [文献标识码] A [文章编号] 1672-4062(2019)03(b)-0089-02

    [Abstract] Objective To investigate the effect of high-dose dexamethasone in the treatment of adult primary immune thrombocytopenia with diabetes. Methods Twenty-two patients with ITP and diabetes mellitus admitted to our department from May 2016 to May 2018 were randomly divided into two groups： 11 patients each. The observation group received high-dose dexamethasone and the control group received prednisone. Results The total effective rate of the observation group was 81.8% ......